Article
Preclinical safety assessment of Koomba kaat 1 and Biyabeda mokiny 1 phages for respiratory application against <i>Staphylococcus aureus</i>
2026-07-26
Abstract excerpt
Therapeutic bacteriophages are promising alternatives to antibiotics for treating antimicrobial-resistant bacterial infections. For pulmonary infections, direct respiratory delivery offers therapeutic advantages; however, preclinical evaluation of respiratory safety remains underdeveloped. Bacteriophages exhibit genomic and biological diversity, and safety cannot be assumed for individual candidates. Here, we eval...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced biosensing and bioanalysis techniques
- Antimicrobial Resistance in Staphylococcus
- Bacteriophages and microbial interactions
- Inhalation and Respiratory Drug Delivery
- Microbial infections and disease research
- Monoclonal and Polyclonal Antibodies Research
- Mycobacterium research and diagnosis
- Respiratory viral infections research
Identifiers and source
- Literature Corpus work
- 66e204e5-3197-5fdb-9d14-42f4e8ad8fa0
- DOI
- 10.64898/2026.07.24.740517
